AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $980,000 | +92.5% | 28,450 | -6.6% | 0.00% | – |
| Q2 2020 | $509,000 | +17.3% | 30,467 | +1.3% | 0.00% | – |
| Q1 2020 | $434,000 | -59.7% | 30,066 | -6.6% | 0.00% | -100.0% |
| Q4 2019 | $1,077,000 | +163.3% | 32,180 | +64.6% | 0.00% | – |
| Q3 2019 | $409,000 | +0.5% | 19,550 | 0.0% | 0.00% | – |
| Q2 2019 | $407,000 | -1.5% | 19,550 | +5.8% | 0.00% | – |
| Q1 2019 | $413,000 | -5.5% | 18,481 | +1.1% | 0.00% | – |
| Q4 2018 | $437,000 | +13.2% | 18,273 | +29.1% | 0.00% | – |
| Q3 2018 | $386,000 | +1.3% | 14,150 | 0.0% | 0.00% | – |
| Q2 2018 | $381,000 | -15.1% | 14,150 | +0.3% | 0.00% | – |
| Q1 2018 | $449,000 | +29.8% | 14,102 | +55.2% | 0.00% | – |
| Q4 2017 | $346,000 | +56.6% | 9,087 | +1.5% | 0.00% | – |
| Q3 2017 | $221,000 | +38.1% | 8,955 | +15.2% | 0.00% | – |
| Q2 2017 | $160,000 | +19.4% | 7,776 | +26.6% | 0.00% | – |
| Q1 2017 | $134,000 | +4.7% | 6,142 | -1.5% | 0.00% | – |
| Q4 2016 | $128,000 | +137.0% | 6,238 | +66.4% | 0.00% | – |
| Q3 2016 | $54,000 | -41.3% | 3,749 | -54.7% | 0.00% | – |
| Q2 2016 | $92,000 | – | 8,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
| Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
| Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
| AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
| Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
| Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
| Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
| EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |